342 related articles for article (PubMed ID: 17673202)
1. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
[TBL] [Abstract][Full Text] [Related]
2. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi.
Amuchástegui PI; Moretti ER; Basso B; Sperandeo N; de Bertorello MM
Rev Argent Microbiol; 1990; 22(4):199-207. PubMed ID: 2129475
[TBL] [Abstract][Full Text] [Related]
3. Trypanocidal effects of promethazine.
Fernández AR; Fretes R; Rubiales S; Lacuara JL; Paglini-Oliva P
Medicina (B Aires); 1997; 57(1):59-63. PubMed ID: 9435371
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
5. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice.
Barr SC; Rose D; Jaynes JM
J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074
[TBL] [Abstract][Full Text] [Related]
6. Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse.
Goodin MG; Bray BJ; Rosengren RJ
Food Chem Toxicol; 2006 Sep; 44(9):1496-504. PubMed ID: 16762473
[TBL] [Abstract][Full Text] [Related]
7. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
8. Anti-trypanosomal activity of (8-hydroxymethylen)-trieicosanyl acetate against infective forms of Trypanosoma cruzi.
Jimenez-Coello M; Acosta-Viana KY; Guzman-Marin E; Perez Gonzalez C; Salud Perez Gutierrez M
Pharm Biol; 2010 Jun; 48(6):666-71. PubMed ID: 20645740
[TBL] [Abstract][Full Text] [Related]
9. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
Arantes JM; Francisco AF; de Abreu Vieira PM; Silva M; Araújo MS; de Carvalho AT; Pedrosa ML; Carneiro CM; Tafuri WL; Martins-Filho OA; Elói-Santos SM
Exp Parasitol; 2011 Aug; 128(4):401-8. PubMed ID: 21620835
[TBL] [Abstract][Full Text] [Related]
11. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
[TBL] [Abstract][Full Text] [Related]
12. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
13. Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo.
de Souza EM; Oliveira GM; Boykin DW; Kumar A; Hu Q; De Nazaré C Soeiro M
J Antimicrob Chemother; 2006 Sep; 58(3):610-4. PubMed ID: 16854954
[TBL] [Abstract][Full Text] [Related]
14. Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins.
Búa J; Fichera LE; Fuchs AG; Potenza M; Dubin M; Wenger RO; Moretti G; Scabone CM; Ruiz AM
Parasitology; 2008 Feb; 135(2):217-28. PubMed ID: 17922928
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.
Silva JJ; Osakabe AL; Pavanelli WR; Silva JS; Franco DW
Br J Pharmacol; 2007 Sep; 152(1):112-21. PubMed ID: 17603548
[TBL] [Abstract][Full Text] [Related]
17. Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi.
Adade CM; Figueiredo RC; De Castro SL; Soares MJ
Acta Trop; 2007 Jan; 101(1):69-79. PubMed ID: 17250794
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
[TBL] [Abstract][Full Text] [Related]
19. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
[TBL] [Abstract][Full Text] [Related]
20. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
